A detailed history of Investors Research Corp transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Investors Research Corp holds 950 shares of DCTH stock, worth $10,792. This represents 0.0% of its overall portfolio holdings.

Number of Shares
950
Previous 1,100 13.64%
Holding current value
$10,792
Previous $9,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$7.36 - $11.0 $1,104 - $1,650
-150 Reduced 13.64%
950 $8,000
Q2 2024

Jul 31, 2024

SELL
$4.47 - $8.37 $8,046 - $15,065
-1,800 Reduced 62.07%
1,100 $9,000
Q1 2024

May 06, 2024

SELL
$3.72 - $5.09 $3,720 - $5,090
-1,000 Reduced 25.64%
2,900 $13,000
Q4 2023

Jan 30, 2024

BUY
$2.25 - $4.17 $8,775 - $16,263
3,900 New
3,900 $16,000

Others Institutions Holding DCTH

About DELCATH SYSTEMS, INC.


  • Ticker DCTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,597,680
  • Market Cap $97.7M
  • Description
  • Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...
More about DCTH
Track This Portfolio

Track Investors Research Corp Portfolio

Follow Investors Research Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

News

Stay updated on Investors Research Corp with notifications on news.